Bronchiectasis is a chronic respiratory condition characterized by permanent, abnormal widening and damage to the bronchi — the large airways that carry air into the lungs. This irreversible structural change disrupts the lung’s natural defense mechanisms, leading to mucus accumulation, recurrent infections, and a progressive cycle of airway injury that can significantly impair quality of life and respiratory function over time.

340-522KAdults Affected in US
53-566Per 100K Globally
3xHigher Hospitalization
40-70%Exacerbation Reduction

What Is Bronchiectasis?

Bronchiectasis is a chronic pulmonary disorder defined by permanent, irreversible dilation and destruction of the bronchial walls. The term derives from the Greek: bronkhia (windpipe) and ektasis (dilation). Under healthy conditions, the mucociliary escalator clears mucus efficiently. In bronchiectasis, damaged cilia lose their coordinated beat, excessive mucus is produced, and structural distortion creates pockets where secretions pool and stagnate.

Key Definition: Bronchiectasis is characterized by permanent, abnormal dilation of the bronchi with accompanying wall thickening, loss of mucociliary clearance, chronic bacterial infection, and recurrent inflammation leading to progressive lung damage.

Bronchiectasis Symptoms: What to Watch For

🫁

Chronic Productive Cough

Universal Feature

A daily cough that produces sputum is present in over 90% of patients. Typically worse in the morning upon waking. Sputum volume ranges from 10 mL daily to over 200 mL in severe disease.

🤒

Recurrent Chest Infections

Major Clue

Patients experience frequent exacerbations defined by increased sputum volume/purulence, worsening cough, increased breathlessness, or fever. Some endure 4-6 exacerbations annually.

💨

Shortness of Breath and Wheezing

Clinical Feature

Progressive breathlessness develops as lung function deteriorates. Wheezing and crackles are common, reflecting turbulent airflow through mucus-filled airways.

Emergency warning signs: Coughing up >2 tablespoons of blood, severe difficulty breathing, blue lips/fingertips, confusion or drowsiness, high fever with shaking chills. Call emergency services immediately.

What Causes Bronchiectasis?

Cause CategorySpecific ConditionsFrequency
Post-infectiousSevere pneumonia, pertussis, measles, TB, aspiration20-40%
Cystic fibrosisCFTR gene mutations5-10%
ImmunodeficiencyCVID, IgA deficiency, HIV5-10%
ABPAHypersensitivity to Aspergillus1-5%
IdiopathicNo identifiable cause30-50%

Types of Bronchiectasis

📏

Cylindrical Bronchiectasis

Mild Form

Uniformly dilated airways with straight walls. Most common and mildest form. May be reversible if underlying cause treated early.

🔔

Varicose Bronchiectasis

Intermediate Severity

Irregular, beaded dilation resembling varicose veins. Associated with higher bacterial load and more frequent exacerbations.

🫧

Cystic (Saccular) Bronchiectasis

Most Severe

Large, cyst-like ballooned dilations. Associated with highest sputum volumes, most frequent infections, and poorest prognosis.

How Bronchiectasis Is Diagnosed

High-resolution CT (HRCT) of the chest is the gold standard diagnostic test, with sensitivity and specificity exceeding 95%. Diagnostic criteria include: bronchial lumen diameter larger than accompanying pulmonary artery; failure of bronchi to taper toward the periphery; and visualization of bronchi within 1 cm of the pleural surface. Sputum microbiology identifies colonizing organisms. Pulmonary function testing demonstrates obstructive pattern (reduced FEV1/FVC ratio).

🫁 Get Expert Bronchiectasis Resources

Access comprehensive bronchiectasis management programs, airway clearance training videos, and personalized care planning tools.

Ad Explore Bronchiectasis Care Programs →

Bronchiectasis Treatment: A Comprehensive Approach

  • Airway clearance: Daily physical techniques to mobilize mucus — foundation of all bronchiectasis care
  • Infection management: Prompt antibiotic treatment of exacerbations and long-term prophylaxis
  • Treating underlying causes: Addressing root condition driving bronchiectasis
  • Preventing complications: Vaccination, nutritional optimization, pulmonary rehabilitation

Airway Clearance Techniques: The Cornerstone of Care

Daily airway clearance is the single most important intervention in bronchiectasis management. Consistent, twice-daily clearance reduces sputum retention, lowers bacterial load, decreases exacerbation frequency, and preserves lung function.

Active Cycle of Breathing Technique (ACBT)

Three-phase technique: breathing control (relaxed nasal breathing), thoracic expansion (deep breaths with 3-second hold), and huffing (forceful exhalation with open mouth). Requires no equipment.

Oscillating Positive Expiratory Pressure (OPEP) Devices

Devices like Acapella, Aerobika combine positive expiratory pressure with airway oscillations to vibrate airways and reduce mucus viscosity. Portable and easy to use.

Important: Dornase alfa (Pulmozyme) should NOT be used in non-CF bronchiectasis. Clinical trials demonstrated harm with increased exacerbation rates.

🫁 Personalized Airway Clearance Routine Builder

Morning technique:
Evening technique:
Hydration target:

Antibiotic Therapy in Bronchiectasis

For patients with three or more exacerbations per year, long-term macrolide antibiotics (azithromycin 250-500 mg three times weekly) reduce exacerbation frequency by 40-60%. Before starting macrolides, require ECG, audiometry, liver function tests, and sputum culture to exclude NTM. For chronic Pseudomonas aeruginosa infection, inhaled antibiotics (tobramycin, colistin) deliver high drug concentrations directly to airways. Brensocatib (Brinsupri) is a novel DPP1 inhibitor reducing exacerbations in patients with ≥2 exacerbations/year despite standard treatment.

Safety note: Before long-term macrolides, ECG required to check QT interval (arrhythmia risk). Also exclude NTM infection — macrolide monotherapy induces resistance.

Managing Bronchiectasis Exacerbations

Exacerbations are diagnosed when at least three criteria are met: increased sputum volume, increased sputum purulence, worsening cough, increased breathlessness, fever, hemoptysis, or deterioration in exercise tolerance. Many clinicians provide a “rescue pack” of antibiotics for patients to start at first sign of exacerbation. Prevention strategies: daily airway clearance, smoking cessation, vaccination, long-term antibiotics for frequent exacerbators.

Living Well With Bronchiectasis

Regular exercise improves mucus clearance and strengthens respiratory muscles. A high-protein, anti-inflammatory diet and adequate hydration (≥2L daily) are essential. Many people with bronchiectasis continue working full-time with accommodations. Seek support from pulmonary rehabilitation programs and patient support groups.

🫁 Start Your Journey to Better Bronchiectasis Control

Ad Get Started With Bronchiectasis Programs →

🏆 Editor’s Choice: Top Bronchiectasis Management Resources

RankResourceRating
#1 Top PickComplete Bronchiectasis Care Program
Airway clearance training, exacerbation management
★★★★★ 4.9/5Ad Learn More →
#2Lung Health & Airway Clearance System★★★★★ 4.8/5Ad Learn More →

Sponsored content. We may earn commissions on purchases at no cost to you.

🎯 Bronchiectasis Symptom Assessment Quiz

Progress1 / 8

📊 Bronchiectasis Exacerbation Risk Calculator

Frequently Asked Questions

Is bronchiectasis the same as bronchitis?

No. Bronchitis is inflammation of the bronchi (usually reversible). Bronchiectasis involves permanent structural damage and abnormal widening of the airways visible on CT imaging.

Can bronchiectasis get better or go away?

The structural damage is permanent and irreversible. However, with consistent daily airway clearance and appropriate antibiotics, most patients experience substantial symptom improvement and stabilization of lung function.

Ad Explore comprehensive management programs →
How often should I do airway clearance?

Guidelines recommend at least once daily for all patients, with twice daily recommended for moderate to severe disease, copious sputum, or frequent exacerbations.

📚 References & Sources

  1. Polverino E, et al. European Respiratory Society guidelines for management of adult bronchiectasis. ERJ, 2017.
  2. Hill AT, et al. British Thoracic Society Guideline for bronchiectasis in adults. Thorax, 2019.
  3. Chalmers JD, et al. Phase 2 trial of brensocatib in bronchiectasis (WILLOW). N Engl J Med, 2020.
  4. Altenburg J, et al. Azithromycin maintenance in non-CF bronchiectasis (BAT). JAMA, 2013.